Actinium Pharmaceuticals reported $6.83M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Actinium Pharmaceuticals USD 6.83M 1.48M Sep/2025
Amgen USD 25.49B 3.7B Dec/2025
Bioline Rx USD 13.67M 1.81M Sep/2025
Capricor Therapeutics USD 28.15M 249K Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025